Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Gentex Corporation. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Gentex Corporation (GNTX) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Gentex Corporation (NASDAQ: GNTX).
On October 23, 2026, Gentex Corporation reported its third-quarter 2026 financial results, including net sales of $647.7 million and diluted earnings per share of $0.43, missing analyst consensus estimates of approximately $670 million and $0.50, respectively. The Company disclosed that quarterly revenue was approximately $35 million below its initial forecast due to customer issues and delayed product launches. Gentex also reported a 10% decrease in mirror unit shipments, gross margin contraction to 33.4% from 34.4%, impairment charges, and ongoing tariff and pricing pressure. The Company lowered its full-year revenue guidance to approximately $2.65 billion from its prior range of $2.65–$2.75 billion. Following this news, Gentex’s stock price dropped to a reported 52-week low of $20.31 per share.
What Potential Securities Violations Is BG&G Investigating?
- Whether Gentex Corporation and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether Gentex Corporation failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should Gentex Corporation (GNTX) Investors Do?
How Is Gentex Corporation (NASDAQ: GNTX) Stock Trading Today?
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”